SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-009293
Filing Date
2024-01-17
Accepted
2024-01-17 16:39:35
Documents
16
Period of Report
2024-01-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d730565d8k.htm   iXBRL 8-K 25841
2 EX-99.1 d730565dex991.htm EX-99.1 17264
3 EX-99.2 d730565dex992.htm EX-99.2 10332
7 GRAPHIC g730565g0117005827654.jpg GRAPHIC 2975
8 GRAPHIC g730565g0118013845338.jpg GRAPHIC 2975
  Complete submission text file 0001193125-24-009293.txt   195488

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA btmd-20240117.xsd EX-101.SCH 2832
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20240117_lab.xml EX-101.LAB 17978
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20240117_pre.xml EX-101.PRE 11246
10 EXTRACTED XBRL INSTANCE DOCUMENT d730565d8k_htm.xml XML 3348
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 24538947
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)